Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT02746146
Other study ID # PHRC-I/2015/OM-01
Secondary ID 2016-A00464-47
Status Terminated
Phase N/A
First received
Last updated
Start date April 5, 2017
Est. completion date March 2, 2020

Study information

Verified date February 2021
Source Centre Hospitalier Universitaire de Nimes
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The main objective of this study is to show that the systematic use of a prognostic score as early as possible after the initiation of dialysis in patients over 70 years of age and with a good prognosis at 3 years of dialysis results in an increase in the number of entries on a kidney transplant waiting list at 12 months after the initiation of dialysis. This prospective assessment is carried out as part of a historico-prospective before-after study in parallel with a survey of changes in national practices over the same time period via a here-elsewhere type study. Historical data (i.e the. "before" period) will include incident dialysis cases during the calendar years 2013, 2014 and 2015 before the start of the prospective phase (i.e. "after" period, which is represented by the current declaration); since a preliminary study demonstrated that the data are comparable from 2011 to 2013, we will use the average of data thus obtained. Historical data will be retrieved from the REIN (The French Renal Epidemiology and Information Network) registry data and will be validated by investigators at each center.


Description:

The secondary objectives are: A. To show that the systematic use of the score at the initiation of dialysis can shorten the registration delay on a kidney transplant waiting list; to evaluate the time between initiation of dialysis and registration on a national waiting list for kidney transplants, while assessing the duration of the pre-transplant assessment. B. To identify barriers to registration on the kidney transplant waiting list as well as the related time delay in this population (medical and non-medical factors), the rates and causes of patient refusal for registration and the possible evolution this refusal over time. C. To evaluate the economic impact of the introduction of the renal transplant clinical prognostic score.


Recruitment information / eligibility

Status Terminated
Enrollment 46
Est. completion date March 2, 2020
Est. primary completion date March 2, 2020
Accepts healthy volunteers No
Gender All
Age group 70 Years to 84 Years
Eligibility Inclusion Criteria: - The patient must have given his/her informed and signed consent - The patient must be insured or beneficiary of a health insurance plan - The patient is available for 12 months of follow-up - Patient initiating chronic dialysis (incident cases) - Patients with a 3 year prognostic mortality score less than (<) 10 points (Dusseux et al. 2015) Exclusion Criteria: - The patient is participating in another interventional study - The patient is in an exclusion period determined by a previous study - The patient is under judicial protection, under tutorship or curatorship - The patient refuses to sign the consent - It is impossible to correctly inform the patient - Patient on preemptive kidney transplant waiting list (before the initiation of a chronic dialysis program)

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Systematic use of a prognostic score
The prognostic score is given in Dusseux et al 2015. It will be used as soon as possible after the initiation of dialysis.

Locations

Country Name City State
France Clinique Claude Bernard Albi
France AIDER - Unité de Dialyse d'Alès Alès
France CH d'Auch Auch
France Centre d'Hemodialyse Languedoc Méditérranéen Béziers
France Medipole Grand Sud St Roch Cabestany
France CH de Cahors Cahors
France NephroCare Castelnau le Lez
France CH de Carcassonne Cité De Carcassonne
France AAIR Midi-Pyrénées Colomiers
France Centre Hospitalier Intercommunal du Val d'Ariège Foix Cedex
France Clinique du Pont de Chaume Montauban
France AIDER de Montpellier Montpellier
France CHRU de Montpellier - Hôpital Lapeyronie Montpellier
France Clinique de l'Occitanie Muret Cedex
France Polyclinique Le Languedoc Narbonne
France Gardialyse Nîmes
France CHRU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 09
France AIDER - Unité de Dialyse de Nîmes Nîmes Cedex 9
France CH de Perpignan - Hôpital Saint Jean Perpignan
France Centre Hospitalier Jacques Puel Rodez
France CH de Bigorre Tarbes Cedex 9
France Clinique Néphrologique Saint-Exupéry Toulouse Cedex 4
France CHRU de Toulouse - Hôpital de Rangueil Toulouse Cedex 9
France CHRU de Toulouse - Hôpital Larrey Toulouse Cedex 9
France CHRU de Toulouse - Hôptal Casselardit Toulouse Cedex 9

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier Universitaire de Nimes

Country where clinical trial is conducted

France, 

References & Publications (1)

Dusseux E, Albano L, Fafin C, Hourmant M, Guérin O, Couchoud C, Moranne O. A simple clinical tool to inform the decision-making process to refer elderly incident dialysis patients for kidney transplant evaluation. Kidney Int. 2015 Jul;88(1):121-9. doi: 10.1038/ki.2015.25. Epub 2015 Feb 11. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary The % number of registrants on the kidney transplant waiting list 12 months
Secondary Delay between the initiation of dialysis and inclusion on the kidney transplant waiting list This outcome integrates the the duration of initial assessment and is measured by the difference between the start and end dates of the pre-transplant assessment. 12 months
Secondary The number of refusals by patients for registration on the kidney transplant waiting list 12 months
Secondary In case of patient refusal for registration, the reasons why (qualitative approach) 12 months
Secondary The number of cases where there is a medical contra-indication for registration on the kidney transplant waiting list 12 months
Secondary In case of a medical contra-indication for registration on the kidney transplant waiting list, the cause (qualitative approach) 12 months
Secondary The cost of care associated with dialysis patients and dialysed-and-then-transplanted patients will be estimated from the point of view of the French health insurance system 12 months
See also
  Status Clinical Trial Phase
Completed NCT03246984 - VALUE- Vascular Access Laminate eUropean Experience. A Post Market Surveillance Study to Assess the Safety and Effectiveness of VasQ N/A
Completed NCT02922361 - Spending and Outcomes for Complex Medicare Advantage Patients
Completed NCT02235571 - iChoose Decision Kidney Aid for End-Stage Renal Disease Patients N/A
Completed NCT01922843 - A Phase 2 Study of an Oral Vitamin D Compound (DP001) in Secondary Hyperparathyroidism in Patients on Hemodialysis Phase 2
Completed NCT01930396 - Use of Tinzaparin for Anticoagulation in Hemodialysis Phase 4
Completed NCT01933789 - Improving Communication About Serious Illness N/A
Not yet recruiting NCT01674660 - Factors Associated With Interdialytic Blood Pressure Variability in Maintenance Hemodialysis Patients N/A
Not yet recruiting NCT01157260 - The Effects of AST-120 on Endothelial Dysfunction in Patients With Chronic Kidney Disease Phase 4
Completed NCT01209403 - Insulin-like Growth Factor (IGF-I) in Hemodialysis Patients Phase 4
Completed NCT00753116 - Renal Denervation in End Stage Renal Disease Patients With Refractory Hypertension Phase 1
Recruiting NCT00532688 - N-Acetylcysteine in Heart Failure With Coexistent Chronic Renal Failure Phase 2/Phase 3
Completed NCT00534144 - Comparison Between Effects of Two Iron Preparations on Protein in the Urine Phase 1
Completed NCT00528788 - How Vitamin D Analogues Affect Endothelial Cells in Patients on Dialysis Phase 4
Completed NCT00382044 - Audit of the Effect of Changing From IV to SC Administration of ESA's in Haemodialysis Patients N/A
Completed NCT00226902 - Vascular Reactivity in Kidney Disease Patients N/A
Recruiting NCT00235287 - Pulse Wave Velocity, Pulse Wave Morphology and Blocking of the Reninangiotensin System in Patients With Chronic Kidney Disease Phase 4
Completed NCT00224081 - DRIVE Trial (Dialysis Patients' Response to Intravenous [IV] Iron With Elevated Ferritin) Phase 4
Completed NCT00071214 - Study to Evaluate the Effectiveness of StaphVAX in Adults on Hemodialysis Phase 3
Completed NCT00049907 - Cardiac and Renal Disease Study (CARDS) N/A
Completed NCT00006297 - Risk Factors for CV Disease in a Dialysis Cohort N/A